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Several studies have validated successful mandibular reconstruction with prefabricated tissue engi
neered bone flaps and recombinant human bone morphogenetic protein 2 (rhBMP 2) implanted in situ.
Whether rhBMP 2 applied with the prefabrication technique enables faster ossification of mandibular
defects than rhBMP 2 applied in situ is unknown. We aimed to compare mandibular reconstruction with
prefabricated, vascularized tissue engineered bone flaps with rhBMP 2 and rhBMP 2 applied in situ in
primates (Rhesus monkey). We also compared the use of the carriers demineralized freeze dried bone
allograft (DFDBA) and coralline hydroxyapatite (CHA) for applying rhBMP 2. After computed tomography
of the monkey head, custom meshes were made, loaded with rhBMP 2 incorporated DFDBA or CHA, and
implanted in the latissimus dorsi muscle. Meanwhile, contralateral segmental mandibular defects were
created, and custom meshes loaded with DFDBA, CHA, or rhBMP 2 incooperated DFDBA and CHA were
implanted in situ. Thirteen weeks later, the bone flaps with rhBMP 2 incorporated DFDBA or CHA were
transferred to repair segmental mandibular defects. The meshes loaded with DFDBA or CHA alone
showed no bone regeneration 13 weeks after implantation in latissimus dorsi muscle. Radiography,
angiography and histological analysis were used to evaluate the repair and vascularization of the implant.
Segmental mandibular defects were successfully restored with prefabricated bone flaps and rhBMP 2
incorporated CHA in situ, but other segmental mandibular defects remained with rhBMP 2 incorporated
DFDBA, DFDBA and CHA in situ. Moreover, mandibles reconstructed with rhBMP 2 incorporated CHA
bone flaps revealed more regenerated and homogeneous bone formation than did other reconstructions.
The study suggested that the prefabrication technique induced better mandibular reconstruction and
bone regeneration in quantity and quality.
 2010 Elsevier Ltd. All rights reserved.1. Introduction
The restoration of mandibular defects caused by ablative
surgery for oral and maxillofacial tumor, trauma, infection and
congenital deformity remains a challenge for surgeons [1]. Autol
ogous grafting and distraction osteogenesis are the most common
techniques used to restore mandibular defects [2]. Autologous
grafts have been considered the “gold standard” because of the
advantages of osteogenesis, osteoinduction and osteoconduction.: þ86 10 62173402.
All rights reserved.
al., Primate mandibular reco
als.2010.02.072However, the major drawbacks of these methods are severe
morbidity, as well as donor site availability, which calls for new
methods for mandibular reconstruction [1]. At present, bone tissue
engineering has gone from the bench to the bedside and shown
effectiveness in mandibular reconstruction [3e5].
Recombinant human bone morphogenetic protein 2 (rhBMP 2)
is the growth factor most widely used for bone regeneration in
clinical practice [6,7]. Two major techniques for use of rhBMP 2 in
mandibular reconstruction are (1) applying rhBMP 2 in situ [8,9]
and (2) applying rhBMP 2 to muscles adjoining major vessels for
vascularized tissue engineered bone flap prefabricated in vivo,
which is transferred to the jaw defect [3,4,10]. Both of these tech
niques achieved initial clinical success. The prefabrication tech
nique provided a stable blood supply, mature bone and more softnstructionwith prefabricated, vascularized tissue engineered bone...,
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preceding radiotherapy and scars in situ. Animal studies also vali
dated the effectiveness of the 2 methods in mandibular recon
struction [11e13]. Whether the prefabrication technique enables
faster ossification than with recombinant human bone morpho
genetic proteins (rhBMPs) implanted in situ is still unknown,
especially for large compound mandibular defects.
Carriers are used to increase the retention of rhBMPs at ortho
paedic treatment sites for a sufficient period of time to allow
regenerative tissue to form cells that migrate to the area of injury
and to proliferate and differentiate [14]. The four major categories
of carrier materials for rhBMPs include natural polymers, inorganic
materials, synthetic polymers and composites of these materials
[15]. Demineralized freeze dried bone allograft (DFDBA) and
coralline hydroxyapatite (CHA) have been studied as carriers for
rhBMP 2. Clokie et al. reconstructed 10 mandibular defects with
a construct containing osteogenetic protein 1 (OP 1) in a deminer
alized bone matrix suspended in a reverse phase medium to effect
sustained rhBMPs delivery [9]. Heliotis et al. reconstructed a human
mandibular defect with a prefabricated tissue engineered bone flap
by implanting OP 1 coated CHA in the pectoralis major muscle [10].
However, none of the research compared the ossification with
ectopic or orthotopic rhBMP 2 incorporated DFDBA or CHA
carriers.
We aimed to compare the effectiveness of rhBMP 2 applied in
situ and applied in muscle of a prefabricated, vascularized tissue
engineered bone flap for mandibular reconstruction. DFDBA and
CHA were also evaluated as constructs in mandibular
reconstruction.
2. Materials and methods
2.1. Manufacture and specification of DFDBA and CHA
DFDBA was made from the control group of a pharmacokinetics study of
recombinant human stem cell growth factors in Rhesus monkeys (Beijing Joinn
Laboratories, China). The donor Rhesus monkeys were healthy and 6 8 years old.
Briefly, the spongy bone was obtained from the extremities and reserved at 70 C
for 2 months to extinguish immunogenicity. The spongy bone was separated from
the head of extremities and cut into 2 sizes: scaffold “A” with upper plane 10 mm 
3 mm, lower plane 10 mm  6 mm and height 5 mm; and scaffold “B” with size 10
mm  6mm  5 mm. The bone blocks were then soaked in acetone for 48 hr to
remove the fatty composition. Distilled water was used to wash out bone marrow
and rudimentary blood, then the bone block sample was demineralized with 0.6 M
HCL and washed with distilled water, then freeze-dried. The CHA scaffold was
provided by Yihuajian Commercial Co. Ltd. (China). It was manufactured as for the
DFDBA scaffold. Then, the samples were prepared by hydrothermal chemical ex-
change with phosphate as per the manufacturer's protocol (Yihuajian Commercial
Co. Ltd.). The porous morphology of the carriers was analyzed by scanning electron
microscopy (SEM, JOEL, Model JSM-5600LV). The sample was freeze-dried and pre-
pared for rhBMP-2 incorporation.
2.2. rhBMP-2 delivery
rhBMP-2 was produced by recombinant expression in Escherichia coli at the
Genetic Institute of Huadong Medicine (China) and purified to more than 98%.
Hangzhou Future Biotech Co. Ltd. (China) supplied the rhBMP-2 used in the exper-
iment. rhBMP-2 (72 mg) was dissolved in gelatin solution in acetic acid (30 mg/ml).
One block of each carrier was soaked in 1 ml gelatin solution with rhBMP-2 (1.5
mg/ml) (DFDBA-BMP and CHA-BMP, respectively). rhBMP-2-incorporated scaffolds
were freeze-dried in frozen tubes and kept at 2 7 C until use.
DFDBA and CHA scaffolds coated with gelatin but without rhBMP-2 were also
prepared. Particles of CHA and DFDBA (size: 0.4 1.0 mm) were prepared.
2.3. Experimental design
Nine adult male healthy Rhesus monkeys (6 9 years old, 6 12 kg) were provided
by the Laboratory Animal Center of the Chinese PLA General Hospital (China).
Surgical techniques and animal care conformed to the principles of the Laboratory
Animal Center (NIH publication No. 85-23, revised 1985). For prefabricating tissue-
engineered bone flaps, custom meshes loaded with DFDBA-BMP (n 3), CHA-BMP (n
3), DFDBA (n 3) and CHA (n 3) were implanted in animals'Please cite this article in press as: Zhou M, et al., Primate mandibular reco
Biomaterials (2010), doi:10.1016/j.biomaterials.2010.02.072ambilateral latissimus dorsi muscle. Thirteen weeks later, ossification was validated
in the groups of DFDBA-BMP and CHA-BMP, while no ossification was found in the
other groups. Then, the prefabricated tissue-engineered bone flaps with ossification
were transferred to repair homolateral segmental mandibular defects. At the time of
surgical implantation in the latissimus dorsi muscle, contralateral segmental
mandibular defects described below were implanted with DFDBA-BMP, CHA-BMP,
DFDBA and CHA respectively.
The bilateral mandibular defects in 9 monkeys were randomized into 6 groups
for treatment: P-DFDBA-BMP and P-CHA-BMP: mandibular defect repaired by pre-
fabricated tissue-engineered bone flap with DFDBA-BMP and CHA-BMP, respectively
(n 3 each); S-DFDBA-BMP and S-CHA-BMP: mandibular defect repaired by in situ
DFDBA-BMP and CHA-BMP, respectively (n 3 each); and S-DFDBA and S-CHA:
mandibular defect repaired by in situ DFDBA and CHA, respectively (n 3 each). The
study was approved by the Animal Care and Experiment Committee of Peking
University Health Science Center.
2.4. Manufacture of custom titanium mesh
3-D computed tomography (CT) images were taken of the heads of monkeys.
The scanning data were uploaded to a computer-aided design program, 3-D medi-
cine surface rendering (3DMSR, JIMAFEI Science and Technology Development Co.
Ltd., China) software system. A 20-mm-long mandibulectomy was virtually created
in the mandibular body (Fig. 1a and b). Then, the data were transferred to a milling
machine (GSVM6540, Gold SunMould & CNCmachinery Co. Ltd., China). The custom
titanium meshes for internal fixation of the stumps of the mandible were made by
the machine. The meshes were used to shape the tissue-engineered bone in the
latissimus dorsi muscle and internal fixation of mandibular stumps. The buccal and
lingual height of the mesh was 12 and 10 mm, respectively (Fig. 1c and d).
2.5. Surgical procedures
General anesthesia was induced with ketamine hydrochloride (20 mg/kg
intramuscularly or subcutaneously) and maintained with pentobarbital sodium
(1 2%, intravenously). The monkeys were prepared for extraction of mandibular
teeth from the bicuspid tooth to the back molar. Three months after extraction, the
wounds of the socket healed for the next segmental mandibulectomy.
With monkeys under general anesthesia, the latissimus dorsi muscle was
visualized through a lateral approach, and a pouchwasmade inside themuscle close
to the thoracodorsal artery. The custom mesh was loaded with 4 blocks of scaffold
(containing 2 A and B, respectively). The particles of DFDBA or CHA scaffolds were
mixed with the blood from the surgery. Then the mixture was used to fill the gap
between the block and the custom mesh. The pre-loaded titanium mesh was
implanted into the pouch of the latissimus dorsi muscle of anesthetized monkeys
(Fig. 2a c). Thirteenweeks after implantation, the flap was harvested along with the
adjoining part of the latissimus dorsi muscle containing the thoracodorsal artery and
vein, which supplied blood to the bone flap. The bone flapwas biopsied (Fig. 2d). The
segmental mandibular defect was carried out as follows. After a sub-mandibular
incision, the mandible was exposed extra-orally through a full-thickness flap that
included the periosteum. A 20-mm-wide section of the mandible from the bicuspid
tooth to the backmolar teeth was resected with a fissure bur (Fig. 2e). The volume of
the defect was approximately 3 cm3 (20 mm 10 mm 15 mm). The wound of the
defect was irrigated with normal saline. The prefabricated tissue-engineered bone
flap was then transferred to the mandibular defect via a tunnel created beneath the
major pectoral muscle (Fig. 2f). For study the bone regeneration with rhBMPs or
scaffold alone implanted in situ, the titanium mesh loaded with DFDBA-BMP, CHA-
BMP, DFDBA or CHA was fixed onto the stumps of the contralateral mandibular
defects with titanium micro-osteosynthesis screws.
2.6. Clinical view, angiography and radiography examinations
Postoperative activities, emotional response, food intake and would healing of
surgical sites were observed in all animals. The status of bone regeneration of the
custom meshes loaded with DFDBA-BMP and CHA-BMP were examined during
transplantation. At 26 weeks after implantation, animals were sacrificed by intra-
venous overdose of sodium pentobarbitone, and mandibles and loaded custom
meshes were excised. In 2 Rhesus monkeys, the lingual side of the mesh was inte-
grated with the regenerated bone and was saved.
Mandibular radiogram was obtained (X-mind AC, ACTEON, France). The area of
the bone regenerated in the mandibular defect was analyzed by the Leica image
analysis system.
Angiography was performed before sacrifice in 4 animals to validate the blood
supply of the prefabricated tissue-engineered bone flap. The latissimus dorsi
muscles containing the titanium meshes were dissected. Two veins and 1 artery
were in the thoracodorsal vascular bundle. One thoracodorsal artery was cannu-
lated. Subsequently, the graft was perfused at 37 C with 130 mmHg pressure and
100 ml of 49 ml normal saline, 50 ml Ultra-vist370 (Bayer Schering Pharma.,
Germany) and 10000 U heparin. In 2 Rhesus monkeys, angiography of the distal end
of the thoracodorsal artery was performed to validate the relation of the thor-
acodorsal artery to the transferred tissue-engineered bone flap.nstructionwith prefabricated, vascularized tissue engineered bone...,
Fig. 1. Virtual segmental osteotomy of Rhesus monkey mandible and designed custom titanium meshes. (a) Resecting the mandible with length 20 mm; (b) Mandibular defect after
virtual osteotomy; (c) Lateral view of the mesh on the outer surface of the mandible; (d) Occlusional view of the mesh.
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For simultaneous sequential intravital staining of the regenerated bone, intra-
peritoneal injection of fluorochromes began at 2 weeks after implantation with the
custommeshes. Alizarin-complexion (3% in 2% NaHCO3solution, 0.8ml/kg bodyweight)
was injected 2 and 4 weeks after implantation. Tetracycline (1% in normal saline, 1
ml/kg body weight) was injected 8 and 10 weeks after implantation. Xylenol orange
(6% in 2% NaHCO3 solution, 1.5 ml/kg body weight) was injected 14 and 18 weeks
after implantation. Calcein (1% in 2% NaHCO3 solution, 5 ml/kg body weight)
was injected 22 and 24 weeks after implantation (all fluorochromes from Sigma).
Mandibular biopsy specimens taken during surgery were fixed in 10% neutral
buffered formalin. After dehydration, specimens were immersed in Technovit
7200VLC (Heraeus-Kulzer, Germany). After solidification for 24 hr, specimens were
cut from the longitude of mandibles. Tissues with P-CHA and P-DFDBA inside the
titanium meshes were separated for histological examination. Histological prepara-
tion was previously described [16]. The embedded samples were cut into thin sec-
tions approximately 40 80 mm, and mounted on glass slides. Three ground sections
from each specimen block, 300 mm apart, were stained with haematoxylin and eos-
in (H&E). Histomorphometry involved the Leica image analysis system.
2.8. Statistical analysis
Data from radiography and histology are expressed as mean  s.e.m and were
analyzed by one-way ANOVA. The differences between 2 groups among the 6 groups
were assessed with the Student Newman Kewls test. P < 0.05 was considered stat-
istically significant.3. Results
3.1. Properties of DFDBA and CHA
To study the retention of ectopic and orthotopically adminis
tered rhBMP 2, we chosed the two classical carriers for
rhBMPs, DFDBA and CHA. The DFDBA prepared from the
extremities of rhesus monkeys was considered an allograft. The
porous structure of DFDBA enabled rhBMP 2 to infiltrate deeply
into the carrier and release slowly after implantation. SEM of
DFDBA revealed no osteoblast or crystal structure on the scaf-
fold surface. The mean size of the pores in the trabecular zonePlease cite this article in press as: Zhou M, et al., Primate mandibular reco
Biomaterials (2010), doi:10.1016/j.biomaterials.2010.02.072was larger than that in cortical bone (400e600 mm [Fig. 3a]
and 100e200 mm, respec tively). SEM of CHA revealed a porous
structure. The pore size of CHA was 270e550 mm (Fig. 3b), which
was similar to the structure of human trabecular bone. Many
hydroxyapatite crystals adhered to the surface. The porous
structure enables blood capillary sprout, nutrient diffusion and
bone ingrowth to the scaffold.
3.2. Gross view, angiography and radiography examinations
All wounds healed. No sign of flap necrosis was visible during
the postoperative period. Postoperative swelling was noted in all
animals. The swelling of the latissimus dorsi muscle with DFDBA
BMP and CHA BMP implants lasted longer than that with DFDBA or
CHA implants alone. The titaniummeshes loaded with DFDBA BMP
and CHA BMP showed ossification inside the mesh. No overgrowth
of the regenerated bone was found outside the mesh, and no
osteointegration with the titanium meshes occurred. Meshes
loaded with DFDBA BMP or CHA BMP were encapsulated by the
latissimus dorsi muscle. The volume of the bone regenerated was
larger with CHA BMP than DFDBA BMP loading. No bone induction
was found inmeshes loadedwith DFDBA, and the inner space of the
meshes was occupied by the latissimus dorsi muscle. With the CHA
loading, nearly 50% of the implant had disappeared, and the rest of
CHA was the block encapsulated by the latissimus dorsi muscle
(data not shown).
Angiography was used to study the blood supply with trans
ferred tissue engineered bone flaps and validate the relation of the
thoracodorsal bundle to the implant. The transferred thoracodorsal
bundle was located from the axillary fossa to the repaired
mandibular defect, which validated that the transferred tissue
engineered bone flap was supplied by the thoracodorsal artery and
vein (Fig. 4a). Thoracodorsal arteries had one main trunk and 2e4
branches. The thoracodorsal vein had 2 trunks. Angiography alsonstructionwith prefabricated, vascularized tissue engineered bone...,
Fig. 2. Surgical procedures to transfer the prefabricated tissue-engineered bone flap to repair segmental mandibular defect. (a) Custom titanium mesh loaded with rhBMP-2-
incorporated DFDBA or CHA scaffold; (b) The mesh loaded with biomaterials (white arrow) was implanted into the latissimus dorsi muscle; (c) The prefabricated tissue-engineered
bone flap was located in the latissimus dorsi muscle 13 weeks after implantation (white arrow); (d) Biopsy (white arrow) of the bone flap conducted during transfer. Copious blood
supply in the tissue-engineered flap was visualized; (e) A 20-mm segmental mandibular defect was created; (f) The tissue-engineered bone flap (white arrow) was transferred to
reconstruct the segmental mandibular defect.
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dorsi muscle, which enabled faster vascularization of the tissue
engineered bone flaps (Fig. 4b).
Lateral and vertical radiography was used to evaluate bone
regeneration and healing in the mandibular defect. With P DFDBA
BMP implants, the height of the regenerated bone was comparable
to that of the adjacentmandible. Thewidth of the regenerated bone
was less than that of normal mandible. Mandibular defects were
reconstructed successfully. The block of DFDBA was invisible. The
boundary between the regenerated bone and the adjacent
mandible had disappeared. With P CHA BMP implants, the height
and shape of the bone regenerated was similar to that of the
adjacent mandible. The block of CHA was partly absorbed. The gap
between the CHA blocks was filled by newly formed bone. The
mandibular defect was fully repaired. With S DFDBA BMPPlease cite this article in press as: Zhou M, et al., Primate mandibular reco
Biomaterials (2010), doi:10.1016/j.biomaterials.2010.02.072implants, the blocks of DFDBA had disappeared. Half of the
mandibular defects were occupied by newly formed bone. The
discontinuity of the mandible remained. With S CHA BMP
implants, the CHA blocks were partly absorbed. Bone defects were
apparent in the buccal side of regenerated bone. The mandibular
continuity was restored. With S DFDBA and S CHA implants, the
mandibular discontinuity was remained. With S DFDBA implants,
the DFDBA blocks were invisible in the defect. The CHA blocks
showed a uniformly higher radiopacity in the mandibular defect
with P CHA BMP and S CHA BMP than S CHA implants, which
validated the bone ingrowth to the carrier. The lingual side of the
mandibular defect showed homogeneous bone regeneration
induced by the lingual periosteum (Fig. 5).
In agreement with the radiography examination, the gross view
of mandibular reconstruction showed perfect bone union with Pnstructionwith prefabricated, vascularized tissue engineered bone...,
Fig. 3. Scanning electronic microscopy examination of DFDBA and CHA scaffolds. 3-D
porous structure of (a) DFDBA and (b) CHA.
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of the reconstructed bone showed bone overgrowth around the
titanium mesh. With P DFDBA BMP, P CHA BMP and S CHA BMP
implants, bone defects were revealed in buccal side of the custom
mesh. Soft tissue appeared in the gap between the regenerated
bone and the buccal side of themesh. Mandibular defects werewellFig. 4. (a) Angiography of the mandibular defect repaired by the prefabricated tissue-engin
copious blood supply of the bone flap located in the latissimus dorsi muscle.
Please cite this article in press as: Zhou M, et al., Primate mandibular reco
Biomaterials (2010), doi:10.1016/j.biomaterials.2010.02.072reconstructed with P DFDBA BMP, P CHA BMP and S CHA BMP
implants but were poorly reconstructed with S DFDBA BMP, S
CHA, and S DFDBA implants. With S DFDBA BMP implants, half of
the area of the defect was occupied by bone regenerated from the 2
ends to the center. The center of the defect was occupied by soft
tissues (data not shown).3.3. Histology
Fluorescent labeling was detected in the regenerated bone in all
specimens except for those with S DFDBA and S CHA implants.
Alizarin complexion was absent from all groups. Labeling with
tetracycline, xylenol orange and calcein revealed continual bone
deposition. In the pores of the scaffold, bone label sequences revealed
the direction of bone deposition. Bone remodeling was validated by
interrupted bone labeling and new bone deposition (Fig. 6).
Histological examination of the prefabricated tissue engineered
bone flap in the latissimus dorsi muscle showed rigorous bone
regeneration around the carrier. P DFDBA BMP implants showed
the formation of mature bone, large bone trabecula, bone marrow
and a small area of unabsorbed DFDBA. The osteoblasts lined the
regenerated trabecula. P CHA BMP implants showed bone marrow
predominantly present in the interconnecting pores of CHA. New
bone formed on the surface of the CHA. The morphology of CHA did
not change greatly. With P DFDBA implants, the inner part of the
mesh was occupied by soft tissue, and no bone formed. Most of the
DFDBA implanted in the mesh was resorbed. With P CHA implants,
no bone was induced. The meshes were occupied by muscles
encapsulating the CHA block (data not shown).
Photomicrographsof histological slices of themandible are shown
in Fig. 7. With P DFDBA BMP, P CHA BMP and S CHA BMP implants,
the mandibular defects were reconstructed successfully. The area of
calcification with regenerated bone showed interposition of islands
of the latissimus dorsi muscle (data not shown). The outside of the
meshes was partly osteointegrated with the regenerated bone. The
inside of the meshes did not osteointegrate with the transferred
tissue engineered bone. The height and volume of the regenerated
mandible was comparable in P CHA BMP and S CHA BMP implants.
The area of bone regenerated in the mandibular defect was greater
with P CHA BMP than P DFDBA BMP implants. The bone regen
erated was greater with P CHA BMP than S CHA BMP implants. The
bone regeneratedwith S DFDBA BMP, S DFDBA and S CHA implants
was too limited to reconstruct the continuity.eered bone flap, which was supplied by the thoracodorsal artery. (b) Angiography of
nstructionwith prefabricated, vascularized tissue engineered bone...,
Fig. 5. Radiography of the mandibles reconstructed by the prefabricated tissue-engineered bone flaps or carriers with or without rhBMP-2 incorporated (*P< 0.05).
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This study demonstrated successful mandibular reconstruction
with prefabricated, vascularized tissue engineered bone flaps and
rhBMP 2 implanted in situ. We have compared the techniques of
prefabrication vascularized tissue engineered bone flaps in vivo
and applying rhBMP 2 in situ for mandibular reconstruction.
DFDBA and CHA are known as bone conductive biomaterials for
repairing bone defects. In our study, the segmental mandibular
defects were similar to those commonly occurring in ablative
surgery for malignant tumors in oral and maxillofacial region.
These segmental mandibular defects could be restored with
rhBMP 2 incorporated CHA scaffolds implanted in situ and not
with DFDBA and CHA implanted in situ alone. Therefore, use of
rhBMP 2 incorporation is effective in improving the osteoinduc
tivity of DFDBA and CHA scaffolds.
At present, tissue engineering is compromised by the inability to
adequately vascularize tissues in vivo or in vitro. Vascularization is
one of the hurdles in constructing large bone for clinicalFig. 6. Fluorescence microscopy of bone regenerated in the mandibular defect. Tetracycline
calcein (green) at 22 and 24 weeks. Implantation with (A) P-DFDBA-BMP; (B) P-CHA-BMP
(C) S-DFDBA-BMP; (D) S-CHA-BMP: deposition of the fluorescent indicated along the arro
particles remaining in the mandibular defect. Bar: 100 mm. NB new bone; FT fibrous ti
referred to the web version of this article.]
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Biomaterials (2010), doi:10.1016/j.biomaterials.2010.02.072application, especially for delivering nutrients and removing the
degradation product from biodegradable products [17]. Insufficient
vascularization can lead to slow bone growth and cell death.
Several approaches have achieved initial success in accelerating the
vascularization of the construct in vivo or in vitro; examples include
scaffold design [18], coculture with endothelial cells (ECs) [19],
angiogenic factor delivery [20] and prefabrication in vivo [4]. The
method of prevascularization in vitro takes several days to weeks
for the center of the implant to be perfused. In addition, in vitro
prevascularized constructs have to undergo a process of vessels
from the host anastomosing to the existing vasculature [17]. In our
study, prevascularization in vivo could induce bone regeneration
adjoining the major vessel. As a result, the construct is naturally
connected to the host vasculature. Fast, mature and stable vascu
larization and bone regeneration can be achievedwith this method.
As well, the quantity and quality of bone regeneration with
prefabrication exceeded that with rhBMP 2 implanted in situ alone.
The in vivo prefabrication technique can greatly decrease the time
of vascularization in vitro. The drawbacks of this in vivo(yellow) was given at 8 and 10 weeks, xylenol orange (red) at 14 and 18 weeks, and
: the direction of bone apposition in the pore was from the periphery to the center;
w, starting with yellow to green; (E) S-DFDBA: no new bone formed; (F) S-CHA: CHA
ssue. [For interpretation of the references to color in this figure legend, the reader is
nstructionwith prefabricated, vascularized tissue engineered bone...,
Fig. 7. Histological analysis of the bone regenerated in the reconstructed mandible. Implantation with (a) P-DFDBA-BMP: residue of DFDBA surrounded by newly formed bone;
(b) P-CHA-BMP: formed woven bone and remaining CHA; (c) S-DFDBA-BMP: fibrous tissues in the central of mandibular defect; (d) S-CHA-BMP; (e) S-DFDBA: mandibular defect
mainly occupied by fibrous tissues; (f) S-CHA: scaffold surrounded by fibrous tissues; (g) Histomorphometry of the bone formation in the mandibular defect (*P< 0.05, Bar:
500 mm).
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interventions, a rather longer period in ectopic place and donor site
morbidity in sacrificing the attached muscle [21].
rhBMPs belong to the superfamily of transforming growth factor
b and play a important role in embryonic development, including
brain and bone formation [22,23]. rhBMP 2 induces bone formation
by stimulating mesenchymal stem cells (MSCs) differentiation to
osteoblasts. Several studies also revealed successful reconstruction
of mandibular defects by rhBMP 2 implanted in situ [8,24]. Martine
et al. showed that BMPs stimulate angiogenesis through the
production of vascular endothelial growth factor A by osteoblasts
[25]. In our study, we combined the strategy of vascularization with
rhBMP 2 delivery and implantation with prefabricated bone flaps in
vivo to accelerate the vascularization and bone regeneration of the
tissue engineered bone. rhBMP 2 accelerated the process of capil
lary ingrowth from the muscle to the scaffold. The pedicle of the
prevascularized tissue engineered bone flap enabled amore invasive
surgical procedure and stable blood supply than with common
surgical anastomosis in free transplantation [4,26].
rhBMPs do not remain at therapeutic sites because of rapid
diffusion. Different slow releasing systems and carriers were
developed to control the dispersion of BMPs from the implant site
[14]. An ideal carrier for rhBMPs should be able to maintain a space
or volume for bone regeneration and should be biocompatible,
absorbable, cost effective, and easily manufactured. However, no
favorable carrier has been developed. DFDBA has been widely
studied as a carrier for BMPs [27]. CHA is a porous calcium
carbonate scaffold coated by hydroxyapatite. The main component
of coral is calcium carbonate. The hydroxyapatite coating of CHA
can reduce the resorption of the biomaterials. Therefore, CHA is
a good osteoconductive scaffold for bone growth. The porous
structure of DFDBA and CHA provides an ideal site for MSCs to
adhere, proliferate and differentiate. We used gelatin to maintain
the slow release of the rhBMP 2 in vivo. CHA showed a better slow
release property than did DFDBA. The possible immunologic
rejection and quick resorption of DFDBA may impede the slow
release of rhBMP 2. Therefore, as a carrier for rhBMP 2, CHA was
more stable and effective than DFDBA.
The main component of DFDBA is insoluble, highly cross linked
type I collagen. By defatting and demineralization, natural BMP
adhering to the surface of collagen is exposed, which increases
the osteoinduction of DFDBA. Some studies showed that thePlease cite this article in press as: Zhou M, et al., Primate mandibular reco
Biomaterials (2010), doi:10.1016/j.biomaterials.2010.02.072osteoinduction of BMP incorporated DFDBA was more stable, effec
tive, and longer than that of DFDBA alone [28]. Aspenberg et al.
reported onosteoinduction of DFDBA in rat,mouse and rabbit but not
in monkey, other primates and even humans [28e30]. Paul et al.
found no osteoinduction of DFDBA in human non orthotopic places
[31]. DFDBA from young and adult monkeys showed no osteoin
ductive property in adult monkey muscle, but, rather, induced bone
formation in athymic rat [30]. In our studies, most DFDBA implanted
in latissimus dorsi muscle andmandibular defects was resorbed, and
no bone regenerationwas observed in the latissimus dorsi muscle. In
contrast to the results observed in small experimental animals [30],
the osteoinductivity of DFDBA is decreased in higher species.
We used custom titaniummeshes to shape the regenerated bone.
The custom tissue engineered bone flap could be shaped to the
mandibular defects for better 3 D outcome. The flanges of the custom
mesh were used to fix the regenerated bone to the stump of the
mandible. The hole in the mesh engaged the growth of blood vessel
from the latissimus dorsi muscle to the regenerated bone. To avoid
exposure of the titanium mesh to the oral cavity, the height of the
titaniummeshwas less than thatof the resectedmandible. The lingual
sideof thecustomtitaniummeshwas integratedwith theregenerated
bone but not in the buccal side. Injury of the buccal periosteum in the
mandibular defect may impede the bone regeneration.
Our angiography results showed the blood of the transferred
tissue engineered bone flap was supplied by thoracodorsal artery.
Bone fluorescence labeling of the transferred bone flap validated
the viability and remodeling of the regenerated bone. The amount
of bone regenerated in the reconstructed mandible was larger with
implantation of prefabricated bone flaps thanwith that of rhBMP 2
or scaffolds in situ. Terheyden et al. compared direct application of
OP 1 and prefabricated vascularized bone grafts in the latissimus
dorsi muscle in miniature pigs with mandibular defects [12]. The
authors directly implanted OP 1 incorporated BioOss fixed by
absorbable suture, and the critical size defect was in the mandib
ular angle, and the internal fixation of the implant differed from our
study. The authors found the similar, good results we did with the
prefabrication technique. The prefabrication technique may be
preferable because the blood supply ofmuscles is richer thanwhere
vascular bed is impaired and muscle provides a stable source of
MSCs for cell aggregation and differentiation.
Mandibular defects after ablative surgery of malignant tumor in
oral maxillofacial region, especially in the cases with preoperativenstructionwith prefabricated, vascularized tissue engineered bone...,
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compromised blood supply, short of soft tissues and tissue scarring.
A successful mandibular reconstruction restores both the shape
and function of the mandible, including the contour of the jaw and
its surrounding soft tissues, which minimizes the aesthetic defor
mity and restores mastication. A free composite bone flap is usually
applied in these cases. However, application of this flap is
compromised in some patients because of poor anatomic condition
in the donor site and radiotherapy, for example. The prefabricated
tissue engineered bone flap may be a choice for these composite
mandibular defects. In our study, the prefabricated tissue engi
neered bone flap showed more stable bone regeneration than with
scaffold and rhBMP 2 application alone. When necessary,
a composite musculocutaneous flap with tissue engineered bone
may be designed to reconstruct a large, mandibular defect with soft
tissue loss. This technique can be used as an alternative to vascu
larized autologous bone flap.
We used a primate model to apply the 2 techniques of pre
fabricated tissue engineered bone flaps and applying rhBMP 2 in
situ to repair segmental, mandibular critical size defects. From
animal experiments reported by Boyne [32] and Seto et al. [33], the
width of the mandibular “critical size” defect in the Rhesus
monkey was 20 mm. Therefore, we did not include a control group
in our study. The sample size in each group was limited because of
the expensive animal model, but our study provides a basis for
future study and clinical application.
5. Conclusions
We validated that a prefabricated tissue engineered bone flap
can be used with rhBMP 2 incorporated DFDBA and CHA scaf
folds implanted in Rhesus monkey latissimus dorsi muscle for
mandibular reconstruction. The pedicled prefabricated bone flaps
showed better bone regeneration than did rhBMP 2 incorporated
DFDBA and CHA scaffolds alone in mandibular reconstruction.
The segmental mandibular defects could not be repaired with
DFDBA and CHA implanted without rhBMP 2 in situ. Our results
indicate the feasibility of the use of prefabricated tissue engi
neered bone flap for repair of large, compound mandibular
defects in the clinic.
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Appendix
Figures with essential colour discrimination. Most of the figures
in this article have parts that are difficult to interpret in black and
white. The full colour images can be found in the on line version, at
doi:10.1016/j.biomaterials.2010.02.072.
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